Caption Management LLC Takes $567,000 Position in CorVel Co. (NASDAQ:CRVL)

Caption Management LLC purchased a new stake in shares of CorVel Co. (NASDAQ:CRVL - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 5,100 shares of the business services provider's stock, valued at approximately $567,000.

Other institutional investors have also added to or reduced their stakes in the company. Brevan Howard Capital Management LP increased its position in shares of CorVel by 56.6% in the fourth quarter. Brevan Howard Capital Management LP now owns 1,939 shares of the business services provider's stock valued at $216,000 after acquiring an additional 701 shares during the period. Balyasny Asset Management L.P. increased its holdings in CorVel by 133.4% during the 4th quarter. Balyasny Asset Management L.P. now owns 13,123 shares of the business services provider's stock valued at $1,460,000 after purchasing an additional 7,500 shares during the period. Bank of America Corp DE raised its position in CorVel by 139.9% during the 4th quarter. Bank of America Corp DE now owns 41,787 shares of the business services provider's stock valued at $4,649,000 after purchasing an additional 24,365 shares during the last quarter. Bearing Point Capital LLC purchased a new stake in CorVel in the 4th quarter worth approximately $1,335,000. Finally, Benjamin Edwards Inc. bought a new stake in shares of CorVel in the 4th quarter worth approximately $220,000. Hedge funds and other institutional investors own 51.36% of the company's stock.

CorVel Stock Up 0.3 %

Shares of NASDAQ:CRVL traded up $0.29 on Friday, hitting $112.51. The company had a trading volume of 192,286 shares, compared to its average volume of 119,297. The firm's 50-day simple moving average is $110.67 and its two-hundred day simple moving average is $115.97. The firm has a market capitalization of $5.78 billion, a price-to-earnings ratio of 66.18 and a beta of 1.10. CorVel Co. has a 1 year low of $76.53 and a 1 year high of $128.61.

CorVel (NASDAQ:CRVL - Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

Insider Transactions at CorVel

In related news, CFO Brandon O'brien sold 1,523 shares of the stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $119.56, for a total value of $182,089.88. Following the completion of the transaction, the chief financial officer now directly owns 17,142 shares in the company, valued at $2,049,497.52. This trade represents a 8.16 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Alan Hoops sold 10,200 shares of the company's stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the completion of the sale, the director now owns 118,213 shares in the company, valued at approximately $13,758,811.07. This trade represents a 7.94 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 38,723 shares of company stock valued at $4,522,340. Corporate insiders own 47.57% of the company's stock.

Analyst Ratings Changes

Separately, StockNews.com raised CorVel from a "hold" rating to a "buy" rating in a research note on Friday, April 18th.

CorVel Company Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.